首页|期刊导航|湖南中医杂志|揿针联合枸橼酸莫沙必利治疗肝胃不和型功能性消化不良38例

揿针联合枸橼酸莫沙必利治疗肝胃不和型功能性消化不良38例OA

Clinical effect of press needle combined with mosapride citrate tablets in treatment of functional dys-pepsia with incoordination between liver and stomach:An analysis of 38 cases

中文摘要英文摘要

目的:探究揿针联合枸橼酸莫沙必利治疗肝胃不和型功能性消化不良(functional dyspepsia,FD)的临床疗效.方法:选取肝胃不和型FD患者80例,将其随机分为治疗组与对照组,每组各40例.对照组予枸橼酸莫沙必利片口服治疗,治疗组在对照组基础上加用揿针治疗,2组疗程均为4周.比较2组治疗前后核心症状评分、功能性消化不良症状严重程度(Functional Dyspepsia Symptom Severity,FDSS)评分、尼平消化不良指数(Nepean Dyspepsia Index,NDI)评分、中医证候积分、抑郁自评量表(Self-rating Depression Scale,SDS)评分、汉密尔顿焦虑量表(Hamilton Anxiety Rating Scale,HAMA)评分、尼平消化不良指数生活质量量表(Nepean Dyspepsia Index Quality of Life,NDI-QOL)评分,并评价临床疗效,记录不良反应发生情况.结果:治疗期间,治疗组脱落2例,对照组脱落1例.总有效率治疗组为94.74%(36/38),对照组为82.05%(32/39),2组比较,差异有统计学意义(P<0.05);2组核心症状评分、FDSS评分、NDI评分、中医证候积分、SDS评分、HAMA评分、NDI-QOL评分治疗前后组内比较及治疗后组间比较,差异均有统计学意义(P<0.05);不良反应发生率治疗组为10.53%(4/38),对照组为7.69%,2组比较,差异无统计学意义(P>0.05).结论:揿针联合枸橼酸莫沙必利治疗肝胃不和型FD,能有效减轻临床症状,改善患者生活质量,且安全性佳.

Objective:To investigate the clinical effect of press needle combined with mosapride citrate tablets in the treatment of functional dyspepsia(FD)with incoordination between liver and stomach.Methods:A total of 80 FD patients with incoordination between liver and stomach were randomly divided into treatment group and control group,with 40 patients in each group.The patients in the control group received oral administration of mosapride citrate tablets,while those in the treatment group received press needle in addition to the treatment in the control group,and the course of treat-ment was 4 weeks for both groups.The two groups were compared in terms of core symptom score,Functional Dyspepsia Symptom Severity(FDSS)score,Nepean Dyspepsia Index(NDI)score,traditional Chinese medicine(TCM)syndrome score,Self-rating Depression Scale(SDS)score,Hamilton Anxiety Rating Scale(HAMA)score,and Nepean Dyspepsia Index Quality of Life(NDI-QOL)score.Clinical outcome was assessed,and adverse reactions were recorded.Results:Two patients in the treatment group and 1 patient in the control group were lost during treat-ment.There was a significant difference in overall response rate between the treatment group and the control group[94.74%(36/38)vs 82.05%(32/39),P<0.05].After treatment,both groups had significant changes in core symptom score,FDSS score,NDI score,TCM syndrome score,SDS score,HAMA score,and NDI-QOL score,and there were significant differences in these indicators between the two groups after treatment(P<0.05).There was no significant difference in the incidence rate of adverse reactions between the treatment group and the control group(10.53%vs 7.69%,P>0.05).Conclusion:Press needle combined with mosapride citrate tablets can effectively alleviate clinical symptoms and improve quality of life in the treatment of FD with incoordination between liver and stomach,with a good safety profile.

江雯雯;朱凌宇;费晓燕;陈大隆;沈雷;陈文婷;沈冰洁;季传婷

上海市徐汇区漕河泾街道社区卫生服务中心,上海,200235上海中医药大学附属龙华医院,上海,200321上海中医药大学附属龙华医院,上海,200321上海中医药大学附属龙华医院,上海,200321上海市徐汇区漕河泾街道社区卫生服务中心,上海,200235上海市徐汇区漕河泾街道社区卫生服务中心,上海,200235上海市徐汇区漕河泾街道社区卫生服务中心,上海,200235上海市徐汇区漕河泾街道社区卫生服务中心,上海,200235

医药卫生

功能性消化不良肝胃不和型中西医结合疗法揿针枸橼酸莫沙必利片

functional dyspepsiaincoordination between liver and stomachintegrated traditional Chinese and Western medicine therapypress needlemosapride citrate tablets

《湖南中医杂志》 2026 (7)

30-36,7

上海市徐汇区医学科研项目(SHXH202332)

10.16808/j.cnki.issn1003-7705.2026.07.007

评论